WYOST
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for WYOST, covering 2024-03-05 to 2026-07-08. Get the full timeline:
Most recent: EMA Authorised: Wyost (denosumab) — Sandoz GmbH
5 regulatory and trial events tracked for WYOST, covering 2024-03-05 to 2026-07-08. Get the full timeline:
Most recent: EMA Authorised: Wyost (denosumab) — Sandoz GmbH